NuVasive Announces Fourth Quarter and Full-Year 2022 Financial Results and 2023 Net Sales GuidancePRNewsWire • 02/22/23
NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax PuttyPRNewsWire • 02/21/23
ALERT: The M&A Class Action Firm Announces the Investigation of NuVasive, Inc. - NUVAPRNewsWire • 02/14/23
NUVASIVE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NuVasive, Inc. - NUVABusiness Wire • 02/13/23
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating NuVasive, Inc. BuyoutNewsfile Corp • 02/09/23
Shareholder Alert: Ademi LLP investigates whether NuVasive, Inc. has obtained a Fair Price in its transaction with Globus MedicalPRNewsWire • 02/09/23
NUVA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NuVasive, Inc. Is Fair to ShareholdersBusiness Wire • 02/09/23
NuVasive rallies while Globus Medical moves down after companies announce all-stock merger dealMarket Watch • 02/09/23
Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient CarePRNewsWire • 02/09/23
NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2022 ResultsPRNewsWire • 01/30/23